| scholarly article | Q13442814 |
| P2093 | author name string | Jin Wu | |
| Jie Sun | |||
| Jing Mei | |||
| Xiannian Zheng | |||
| P2860 | cites work | GLP-1 receptor agonists: a review of head-to-head clinical studies | Q26823768 |
| Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes | Q28546539 | ||
| The ADAMTS metalloproteinases | Q29544428 | ||
| The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms. | Q33627749 | ||
| Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis | Q34043042 | ||
| Structure and function of aggrecan | Q34122868 | ||
| ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis | Q34205901 | ||
| Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. | Q34607880 | ||
| Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors | Q34659198 | ||
| GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women | Q35652968 | ||
| Age and obesity are risk factors for adverse events after total hip arthroplasty | Q35663369 | ||
| Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis | Q35927701 | ||
| Circulation and degradation of GIP and GLP-1. | Q36012469 | ||
| Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes | Q36050559 | ||
| The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis | Q36292749 | ||
| Overexpression of Sirtuin 6 suppresses cellular senescence and NF-κB mediated inflammatory responses in osteoarthritis development | Q36350151 | ||
| NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis | Q36490904 | ||
| Exenatide as a treatment for diabetes and obesity: implications for cardiovascular risk reduction | Q37119264 | ||
| The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism. | Q37139985 | ||
| Monocyte chemoattractant protein-1 (MCP-1): an overview | Q37481208 | ||
| Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis | Q38275260 | ||
| Osteoarthitis of leptin-deficient ob/ob mice in response to biomechanical loading in micro-CT. | Q38355351 | ||
| Liraglutide: A New Option for the Treatment of Obesity | Q38615328 | ||
| ROS/oxidative stress signaling in osteoarthritis. | Q38697366 | ||
| Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials | Q40130466 | ||
| Brief Report: JNK-2 Controls Aggrecan Degradation in Murine Articular Cartilage and the Development of Experimental Osteoarthritis. | Q42486191 | ||
| Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes | Q46563144 | ||
| New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis | Q47104080 | ||
| Glucagon-like peptide-1 receptor regulates endoplasmic reticulum stress-induced apoptosis and the associated inflammatory response in chondrocytes and the progression of osteoarthritis in rat. | Q50055684 | ||
| Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. | Q51785699 | ||
| Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density | Q61808072 | ||
| Reactive oxygen species and NADPH oxidase 4 involvement in osteoarthritis | Q90250453 | ||
| A comparative study of the binding properties, dipeptidyl peptidase-4 (DPP-4) inhibitory activity and glucose-lowering efficacy of the DPP-4 inhibitors alogliptin, linagliptin, saxagliptin, sitagliptin and vildagliptin in mice | Q91991783 | ||
| NF-κB Signaling Pathways in Osteoarthritic Cartilage Destruction | Q91994891 | ||
| P433 | issue | 8 | |
| P921 | main subject | osteoarthritis | Q62736 |
| P304 | page(s) | 4800-4808 | |
| P577 | publication date | 2019-08-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Liraglutide suppresses TNF-α-induced degradation of extracellular matrix in human chondrocytes: a therapeutic implication in osteoarthritis | |
| P478 | volume | 11 |
Search more.